RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Rybodyn

Rybodyn

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

Latest funding

$10M Seed ·

Source: SynBioBeta

Latest round on record: Seed, July 2026, amount undisclosed.

All 3 rounds ↓
Website: rybodyn.com.
LinkedIn: rybodyn.
Category: Health and bio.
Sectors: Biotechnology, Medical, Pharmaceutical, Therapeutics.
Stage: Seed.
Based in: San Diego, United States.
Last round: Jul 23, 2026 · 117 days ago.
On Recent Funding since: Oct 2, 2026.

Signals

Website registeredFeb 1, 2022 (4 years old)

Funding rounds

DateRoundAmountLeadSource
Seedundisclosed——
Seed$10M—SynBioBeta

Timeline

  1. IndieBio SF 15
    IIndieBio · batch
    Source: indiebio.co
  2. Website created

Founders and team

Investors

Companies like Rybodyn

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/rybodyn (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy